Kat2b | K(lysine) acetyltransferase 2B
Physiological systems
18 / 24 physiological systems tested
2 Significantly impacted by the knock-out
Homeostasis/metabolism Hematopoietic system
16 No significant impact
6 Not tested
Data collections
Gene metrics:5Significant phenotypes
0Associated diseases
Expression examined in:0Adult tissues
0Embryo tissues
decreased mean corpuscular hemoglobin | 1 supporting dataset | Kat2bem1(IMPC)Wtsi | homozygote | Early adult | 4.31x10-10 | ||
impaired glucose tolerance | 1 supporting dataset | Kat2bem1(IMPC)Wtsi | homozygote | Early adult | 9.33x10-6 | ||
increased red blood cell distribution width | 1 supporting dataset | Kat2bem1(IMPC)Wtsi | homozygote | Early adult | 5.4x10-7 | ||
decreased circulating cholesterol level | 1 supporting dataset | Kat2bem1(IMPC)Wtsi | homozygote | Early adult | 2.73x10-5 | ||
decreased circulating HDL cholesterol level | 1 supporting dataset | Kat2bem1(IMPC)Wtsi | homozygote | Early adult | 1.73x10-5 |
| | | | | | | | | |
External links
No external links available for Kat2b.
All available products are supplied via our member's centres or partnerships. When ordering a product from the IMPC you will be redirected to one of their websites or prompted to start an email.
Kat2bem1(IMPC)Wtsi | Deletion | | mouse |
Kat2btm1a(EUCOMM)Hmgu | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell |
Kat2btm1a(KOMP)Wtsi | KO first allele (reporter-tagged insertion with conditional potential) | | targeting vector ES Cell |
Kat2btm1e(EUCOMM)Hmgu | Targeted, non-conditional allele | | ES Cell |